-
Mashup Score: 3Tricuspid Valve Interventions and its Dubious Evidence - 21 hour(s) ago
The Study of the Week revisits the lessons of VPS I and VPS II to show the failures of tricuspid valve intervention trials
Source: www.sensible-med.comCategories: General Medicine NewsTweet
-
Mashup Score: 3Perhaps the Strongest Benefit of GLP1a drugs is... - 5 day(s) ago
Reports from an ongoing trial in NEJM has flown under the radar but might show a major discovery in Medicine
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
GLP-1 agonists effective in Rxing MASH - metabolic dysfunction-assoc steatohepatitis (AKA NAFLD, NASH). DBRPCT w/ 1100 pts (mean BMI 34-35). A good perspective article from Sensible Medicine. https://t.co/NeaX5qcnPA https://t.co/loRPcwv8B9 https://t.co/ul8ko9cU4K
-
-
Mashup Score: 0Sensible Medicine endorses Vinay Prasad for Director of the Center for Biologics Evaluation and Research (CBER) at the US FDA - 7 day(s) ago
Vinay Prasad is leaving Sensible Medicine to take a senior role at the the US FDA.
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
Sensible Medicine endorses Vinay Prasad for Director of the Center for Biologics Evaluation and Research (CBER) at the US FDA https://t.co/CtVEfuOd88 "It still shocks us how fast Prasad can get to the point of a new study." This and the mention of Prasad's many honors and
-
-
Mashup Score: 28Sensible Medicine endorses Vinay Prasad for Director of the Center for Biologics Evaluation and Research (CBER) at the US FDA - 7 day(s) ago
Vinay Prasad is leaving Sensible Medicine to take a senior role at the the US FDA.
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
Prof @VPrasadMDMPH is slated to be the incoming @FDACBER director at @US_FDA, where he will regulate vaccines as well as cellular and gene therapy. In our opinion, there is no better candidate. https://t.co/ZBDw9SsFOM via @drjohnm & @adamcifu Fully agree 100%. Congrats to Vinay.
-
-
Mashup Score: 442Sensible Medicine endorses Vinay Prasad for Director of the Center for Biologics Evaluation and Research (CBER) at the US FDA - 7 day(s) ago
Vinay Prasad is leaving Sensible Medicine to take a senior role at the the US FDA.
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
A little breaking news on @Sensible__Med Vinay Prasad, Director of the Center for Biologics Evaluation and Research (CBER) at the US FDA https://t.co/YgLliTqqKP
-
-
Mashup Score: 3Perhaps the Strongest Benefit of GLP1a drugs is... - 7 day(s) ago
Reports from an ongoing trial in NEJM has flown under the radar but might show a major discovery in Medicine
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
GLP-1 agonists effective in Rxing MASH - metabolic dysfunction-assoc steatohepatitis (AKA NAFLD, NASH). DBRPCT w/ 1100 pts (mean BMI 34-35). A good perspective article from Sensible Medicine. https://t.co/NeaX5qcnPA https://t.co/loRPcwv8B9 https://t.co/ul8ko9cU4K
-
-
Mashup Score: 9Perhaps the Strongest Benefit of GLP1a drugs is... - 8 day(s) ago
Reports from an ongoing trial in NEJM has flown under the radar but might show a major discovery in Medicine
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
https://t.co/j4tfTSdpNb
-
-
Mashup Score: 16Why oncology? - 9 day(s) ago
What you don’t see on the inpatient service
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
https://t.co/uCxELr4eZQ
-
-
Mashup Score: 13The Train Ride - 9 day(s) ago
“I feel I was meant to see you”
Source: www.sensible-med.comCategories: General Medicine NewsTweet-
https://t.co/zVvctDYaJT
-
-
Mashup Score: 90
My new series
Source: www.sensible-med.comCategories: General Medicine News, Expert PicksTweet-
https://t.co/UWh0z0pcZn https://t.co/sJ4J5Hx1AR
-
Link to @Sensible__Med post: https://t.co/Vqco7W37iQ